BillionaireNet
Punia
Vikram Punia
Rank #1847
RUSSIAHealthcarePharmaceuticals

Vikram Punia

Net Worth
$2.133B
0% (24h)
Vikram Punia, born in India in 1973, is a Russian pharmaceutical magnate with an estimated net worth of $2.1 billion as of late 2025. He is the sole owner of Pharmasyntez, a leading pharmaceutical company in Russia, and a key supplier of drugs under government contracts. Punia's wealth stems from his success in the pharmaceuticals industry, specifically in producing drugs for various diseases, including tuberculosis, HIV, and cancer. His career began after moving to Russia in 1992 as a medical student, later founding Pharmasyntez in 1997. His company's revenue in 2025 was $6.2 billion.

The Full Dossier

Early Life

Vikram Punia was born in Jaipur, Rajasthan, India, in 1973, into a wealthy family. In 1992, at the age of 19, he moved to Irkutsk, Russia, to study medicine at the Far Eastern State Academy of Economics and Management.

Rise to Success

Punia started his entrepreneurial journey in Russia by reselling goods before transitioning to the pharmaceutical industry. He founded Pharmasyntez in 1997 in Irkutsk. The company initially repackaged generic antitubercular medicine imported from India. In 2008, he moved the company's headquarters to Moscow and became a Russian citizen in 2009. By 2010, Punia became the sole owner of Pharmasyntez, growing it into a significant player in the Russian pharmaceutical market. He has been recognized as a rising star in the Russian pharmaceutical industry.

Key Business Strategies

Pharmasyntez has focused on producing high-quality, affordable medicines, particularly for socially significant diseases. Punia expanded the company's reach and operations across Russia, with multiple plants and a wide range of medications. The company has also secured deals with the Russian government, making it a key supplier of drugs.

Philanthropy

Punia's mission goes beyond profits. He is passionate about Russia's pharmaceutical independence, ensuring the country produces world-class medicines.

Career Timeline

2024

Order of Friendship

Conferred the Order of Friendship by decree of the President of the Russian Federation.

2010

Sole Owner of Pharmasyntez

Became the sole owner of Pharmasyntez.

2009

Russian Citizenship

Became a Russian citizen.

1997

Founder of Pharmasyntez

Established his pharmaceutical company in Irkutsk.

1992

Medical Student

Moved to Irkutsk, Russia, to study medicine.

Philanthropic Impact

HealthcareN/A

Supporting Russian Pharmaceutical Independence

Ensuring Russia produces high-quality medicines.

Wealth Trajectory